George A. Truskey

George A. Truskey

R. Eugene and Susie E. Goodson Distinguished Professor of Biomedical Engineering

My research interests focus upon the effect of physical forces on the function of vascular cells and skeletal muscle, cell adhesion, and the design of engineered tissues.  Current research projects examine the  effect of endothelial cell senescence upon permeability to macromolecules and the response to fluid shear stress, the development of microphysiological blood vessels and muscles for evaluation of drug toxicity and the design of engineered endothelialized blood vessels and skeletal muscle bundles.

Appointments and Affiliations

  • R. Eugene and Susie E. Goodson Distinguished Professor of Biomedical Engineering
  • Professor of Biomedical Engineering
  • Affiliate of the Duke Regeneration Center
  • Affiliate of the Duke Initiative for Science & Society

Contact Information

  • Office Location: 1395 Fciemas, 101 Science Drive, Durham, NC 27708-0281
  • Office Phone: (919) 660-5147
  • Email Address: george.truskey@duke.edu
  • Websites:

Education

  • Ph.D. Massachusetts Institute of Technology, 1985
  • B.S.E. University of Pennsylvania, 1979

Research Interests

Cardiovascular tissue engineering, mechanisms of atherogenesis, cell adhesion, and cell biomechanics.

Awards, Honors, and Distinctions

  • AAAS Fellow. American Association for the Advancement of Science. 2014
  • BMES Distinguished Service Award. Biomedical Engineering Society. 2012
  • NIH CSR College of Reviewers. NIH. 2010
  • Capers and Marion McDonald Award for Excellence in Mentoring and Advising. Duke University. 2007
  • Fellow. Biomedical Engineering Society. 2006
  • Fellow. American Institute for Medical and Biological Engineering. 1999
  • Fellow. Council on Arteriosclerosis, Thrombosis and Vascular Biology, American Heart Association. 1999
  • Excellence in Teaching Award. Tau Beta Pi, North Carolina Gamma Chapter. 1998
  • Outstanding Scientific Paper in the Journal of Parenteral Science and Technology. Parenteral Drug Association. 1987

Courses Taught

  • BME 394: Projects in Biomedical Engineering (GE)
  • BME 493-1: Projects in Biomedical Engineering (GE)
  • BME 493: Projects in Biomedical Engineering (GE)
  • BME 494: Projects in Biomedical Engineering (GE)
  • BME 566: Transport Phenomena in Cells and Organs (GE, MC)
  • BME 590: Special Topics in Biomedical Engineering
  • BME 791: Graduate Independent Study
  • BME 792: Continuation of Graduate Independent Study
  • EGR 393: Research Projects in Engineering

In the News

Representative Publications

  • Covert, LT; Patel, H; Osman, A; Duncan, L; Dvergsten, J; Truskey, GA, Effect of type I interferon on engineered pediatric skeletal muscle: a promising model for juvenile dermatomyositis., Rheumatology (Oxford, England), vol 63 no. 1 (2024), pp. 209-217 [10.1093/rheumatology/kead186] [abs].
  • Lee, JH; Shores, KL; Breithaupt, JJ; Lee, CS; Fodera, DM; Kwon, JB; Ettyreddy, AR; Myers, KM; Evison, BJ; Suchowerska, AK; Gersbach, CA; Leong, KW; Truskey, GA, PCSK9 activation promotes early atherosclerosis in a vascular microphysiological system., Apl Bioengineering, vol 7 no. 4 (2023) [10.1063/5.0167440] [abs].
  • Truskey, GA, The Potential of Deep Learning to Advance Clinical Applications of Computational Biomechanics., Bioengineering, vol 10 no. 9 (2023) [10.3390/bioengineering10091066] [abs].
  • Zhang, Q; Zhan, R-Z; Patsy, M; Li, B; Chen, Y; Lipes, BD; Bursac, N; Truskey, GA, Differential Response of Engineered Human Cardiac Tissues to Delta and Omicron COVID-19 Virus., Journal of the American Heart Association, vol 12 no. 12 (2023) [10.1161/JAHA.123.029390] [abs].
  • Abutaleb, NO; Atchison, L; Choi, L; Bedapudi, A; Shores, K; Gete, Y; Cao, K; Truskey, GA, Lonafarnib and everolimus reduce pathology in iPSC-derived tissue engineered blood vessel model of Hutchinson-Gilford Progeria Syndrome., Scientific Reports, vol 13 no. 1 (2023) [10.1038/s41598-023-32035-3] [abs].